Literature DB >> 2541853

Sex-related differences in central adrenergic function and responsiveness to repeated administration of desipramine or electroconvulsive shock.

D J Heal1, L M Bristow, E M Hurst, J M Elliott, W R Buckett.   

Abstract

1. Clonidine induces hypoactivity in rodents. Male rats were found to be markedly more susceptible to the sedative effects of this alpha 2-adrenoceptor agonist than females. Thus to obtain identical hypoactivity responses for subsequent experiments, clonidine was administered to male and female rats at doses of 0.2 and 0.5 mg kg-1, respectively. 2. The clonidine-induced hypoactivity response of female rats was not affected by the oestrous cycle. 3. Repeated injection of desipramine (DMI; 5 mg kg-1 b.d.) for up to 14 days progressively attenuated clonidine-induced hypoactivity in both male and female rats. However, in males the attenuation was more rapid in onset and a greater overall reduction was obtained. This alpha 2-adrenoceptor-mediated response was also progressively reversed by repeated daily administration of an electroconvulsive shock (ECS; 110 V, 1 s). In this case, although the maximum decrease was greater in males, the time of onset was identical in both sexes. 4. There were no sex-related differences in either the number or affinity of alpha 2- and beta-adrenoceptors in rat cortex. Cortical alpha 2-adrenoceptors were decreased by 14 days of DMI injection or 10 days of ECS treatment (ECS x 10) and these effects were identical in both sexes. These receptors were not altered by 2 days administration of DMI or ECS. Cortical beta-adrenoceptors were reduced in male and female rats by 2 and 14 days of DMI injection and by ECS x 10, but not ECS x 2. 5. Viewed overall, the data show differences in alpha 2-adrenoceptor function between the sexes, as determined by clonidine-induced hypoactivity and the responsiveness of this paradigm to repeated administration of DMI and ECS. In contrast, no differences were observed in complementary alpha 2- and beta-adrenoceptor binding experiments using rat cortical tissue.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541853      PMCID: PMC1854465          DOI: 10.1111/j.1476-5381.1989.tb11930.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain.

Authors:  D A Bergstrom; K J Kellar
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Pharmacological characterization of central alpha-adrenoceptors which mediate clonidine-induced locomotor hypoactivity in the developing rat.

Authors:  Y Nomura; K Oki; T Segawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-02       Impact factor: 3.000

5.  Modulation of rat brain alpha- and beta-adrenergic receptor populations by lesion of the dorsal noradrenergic bundle.

Authors:  D C U'Prichard; T D Reisine; S T Mason; H C Fibiger; H I Yamamura
Journal:  Brain Res       Date:  1980-04-07       Impact factor: 3.252

6.  Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment.

Authors:  D A Bergstrom; K J Kellar
Journal:  J Pharmacol Exp Ther       Date:  1979-05       Impact factor: 4.030

7.  Interaction of antidepressants with clonidine on rat brain total 3-methoxy-4-hydroxyphenylglycol.

Authors:  S W Tang; D M Helmeste; H C Stancer
Journal:  Can J Physiol Pharmacol       Date:  1979-04       Impact factor: 2.273

8.  Clonidine: attenuation of sedative action by facilitated central noradrenergic neurotransmission.

Authors:  U Strömbom; T H Svensson
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

9.  Alpha 2-adrenoceptors mediate clonidine-induced sedation in the rat.

Authors:  G M Drew; A J Gower; A S Marriott
Journal:  Br J Pharmacol       Date:  1979-09       Impact factor: 8.739

10.  Effects of chronic desipramine treatment on rat brain noradrenergic responses to alpha-adrenergic drugs.

Authors:  B A McMillen; W Warnack; D C German; P A Shore
Journal:  Eur J Pharmacol       Date:  1980-02-08       Impact factor: 4.432

View more
  4 in total

1.  Extracellular norepinephrine clearance by the norepinephrine transporter is required for skeletal homeostasis.

Authors:  Yun Ma; Jessica J Krueger; Sara N Redmon; Sasidhar Uppuganti; Jeffry S Nyman; Maureen K Hahn; Florent Elefteriou
Journal:  J Biol Chem       Date:  2013-09-04       Impact factor: 5.157

2.  Determination of the role of noradrenergic and 5-hydroxytryptaminergic neurones in postsynaptic alpha 2-adrenoceptor desensitization by desipramine and ECS.

Authors:  D J Heal; M R Prow; W R Buckett
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

3.  Effects of antidepressant drugs and electroconvulsive shock on pre- and postsynaptic alpha 2-adrenoceptor function in the brain: rapid down-regulation by sibutramine hydrochloride.

Authors:  D J Heal; M R Prow; W R Buckett
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Remote Limb Ischemic Preconditioning Attenuates Cerebrovascular Depression During Sinusoidal Galvanic Vestibular Stimulation via α1-Adrenoceptor-Protein Kinase Cε-Endothelial NO Synthase Pathway in Rats.

Authors:  Devin W McBride; Cesar Reis; John H Zhang; Richard Applegate; Jiping Tang
Journal:  J Am Heart Assoc       Date:  2018-03-24       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.